These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1549952)

  • 1. Mineral metabolism in infants with malignant osteopetrosis: heterogeneity in plasma 1,25-dihydroxyvitamin D levels and bone histology.
    Cournot G; Trubert-Thil CL; Petrovic M; Boyle A; Cormier C; Girault D; Fischer A; Garabedian M
    J Bone Miner Res; 1992 Jan; 7(1):1-10. PubMed ID: 1549952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of infantile malignant osteopetrosis: bone mineral metabolism and complications in five infants.
    Reeves J; Arnaud S; Gordon S; Subryan B; Block M; Huffer W; Arnaud C; Mundy G; Haussler M
    Metab Bone Dis Relat Res; 1981; 3(2):135-42. PubMed ID: 6270498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of congenital osteopetrosis with high-dose calcitriol.
    Key L; Carnes D; Cole S; Holtrop M; Bar-Shavit Z; Shapiro F; Arceci R; Steinberg J; Gundberg C; Kahn A
    N Engl J Med; 1984 Feb; 310(7):409-15. PubMed ID: 6546410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable osteoclast appearance in human infantile osteopetrosis.
    Shapiro F; Key LL; Anast C
    Calcif Tissue Int; 1988 Aug; 43(2):67-76. PubMed ID: 3142669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant osteopetrosis: a disease of abnormal osteoclast proliferation.
    Teitelbaum SL; Coccia PF; Brown DM; Kahn AJ
    Metab Bone Dis Relat Res; 1981; 3(2):99-105. PubMed ID: 7289877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF; Hermey DC; Popoff SN; Seifert MF
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of bone resorption by parathyroid hormone in congenital malignant osteopetrosis.
    Glorieux FH; Pettifor JM; Marie PJ; Delvin EE; Travers R; Shepard N
    Metab Bone Dis Relat Res; 1981; 3(2):143-50. PubMed ID: 6974819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human osteopetrosis: a histological, ultrastructural, and biochemical study.
    Shapiro F; Glimcher MJ; Holtrop ME; Tashjian AH; Brickley-Parsons D; Kenzora JE
    J Bone Joint Surg Am; 1980 Apr; 62(3):384-99. PubMed ID: 6245094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia.
    Olgaard K; Finco D; Schwartz J; Arbelaez M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
    Kidney Int; 1984 Dec; 26(6):791-7. PubMed ID: 6335904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
    Parfitt AM
    Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G; Schaefer K; Schulz A; Delling G
    Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
    Kruse K
    J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR; Evans RA; Hills E; Wong SY; Alfrey AC
    Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal remodelling and bone related hormones in two adults with increased bone mass.
    Manzke E; Gruber HE; Hiness RW; Baylink DJ
    Metabolism; 1982 Jan; 31(1):25-32. PubMed ID: 7078404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of parathyroid hormone on bone of thyroparathyroidectomized rats: an ultrastructural and enzymatic study.
    Weisbrode SE; Capen CC; Nagode LA
    Am J Pathol; 1974 Jun; 75(3):529-41. PubMed ID: 4275712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of parathyroid hormone on vitamin D metabolism in osteopetrosis.
    Aarskog D; Aksnes L; Markestad T
    Pediatrics; 1981 Jul; 68(1):109-12. PubMed ID: 6264377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone histology in patients with nephrotic syndrome and normal renal function.
    Mittal SK; Dash SC; Tiwari SC; Agarwal SK; Saxena S; Fishbane S
    Kidney Int; 1999 May; 55(5):1912-9. PubMed ID: 10231454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopetrorickets. The paradox of plenty. Pathophysiology and treatment.
    Kaplan FS; August CS; Fallon MD; Gannon F; Haddad JG
    Clin Orthop Relat Res; 1993 Sep; (294):64-78. PubMed ID: 8395371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of vitamin D metabolites before and during treatment of vitamin D deficiency rickets in children.
    Markestad T; Halvorsen S; Halvorsen KS; Aksnes L; Aarskog D
    Acta Paediatr Scand; 1984 Mar; 73(2):225-31. PubMed ID: 6331057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of vitamin D on parathyroid function in the elderly.
    Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
    J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.